KAP TB in Senior Management Officials of Companies With Increased Silica Exposure
NCT07749872 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 118
Last updated 2026-08-06
Summary
The study was designed as a descriptive cross-sectional survey conducted between February and October 2022. Senior management officials were targeted because of their role in workplace policy and oversight. The sample was drawn from companies registered under the Zambia Chamber of Commerce and Industry (ZACCI), focusing on those with known silica dust exposure. Each company was asked to provide one or two senior officials to participate. A total of 118 individuals completed the survey.
Data collection was carried out using a self-administered electronic questionnaire developed in line with WHO recommendations for TB KAP surveys. The questionnaire contained 28 mandatory closed-ended questions: 7 on knowledge, 8 on attitudes, and 13 on practices (with 5 practice questions excluded from scoring as they were programmatic). Responses were validated by three medical doctors, and scoring was based on correct answers. Knowledge, attitude, and practice scores were categorized into "poor" or "good" using mean or median cutoffs depending on distribution. Logistic regression was applied to explore associations between participant characteristics and KAP outcomes.
Conditions
- TB - Tuberculosis
- Silicosis
- Occupational Exposure
- Occupational Health
Sponsors & Collaborators
-
Centre for Infectious Disease Research in Zambia
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-02-02
- Primary Completion
- 2022-10-15
- Completion
- 2023-02-28
Countries
- Zambia
Study Locations
More Related Trials
-
Adoption of Innovative Approaches to Ensure Continuity of Quality TB Services During COVID-19 Pandemic in Lusaka and Livingstone, Zambia. (Telemedicine in TB)
NCT06883643 ·Status: COMPLETED ·Phase: NA
-
Adjunctive NAC in Adult Patients With Pulmonary Tuberculosis
NCT03702738 ·Status: COMPLETED ·Phase: PHASE2
-
Determining Risk in Latent Tuberculosis
NCT01571739 ·Status: TERMINATED
-
SCAF-TB - Saving Children and Their Families From Tuberculosis: Implementation Research to Improve TB Preventive Treatment Initiation and Completion Rates Among Contact Persons in Tajikistan and Tanzania
NCT07714707 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Influence of Filarial Infections on Tuberculosis Disease and Tuberculosis Vaccination in Cameroon
NCT04547738 ·Status: UNKNOWN
-
A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease
NCT06909799 ·Status: RECRUITING ·Phase: NA
-
The Utility of Intensified Case Finding Combined With a Package of Novel TB Diagnostics Using a Mobile Clinic in Africa
NCT01990274 ·Status: COMPLETED ·Phase: NA
-
Shorter Treatment Regimen Implementation Evaluation Study
NCT07747792 ·Status: COMPLETED
-
Alternative Diagnoses in Patients About to Start Empiric Tuberculosis Treatment
NCT06737029 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Health Personnel and the Assistance to Patients With Tuberculosis in Hospital Environment
NCT00978510 ·Status: COMPLETED
-
Community-based Tuberculosis Tracing and Preventive Therapy
NCT03832023 ·Status: COMPLETED ·Phase: NA
-
Evaluation of PATHFAST-LAM as a Tuberculosis Treatment Monitoring Tool in Kenya
NCT07157904 ·Status: NOT_YET_RECRUITING
-
Prevalence and Burden of Bronchiectasis in Tuberculous Patients
NCT04085133 ·Status: COMPLETED
-
Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV
NCT02043067 ·Status: COMPLETED
-
Latent Tuberculosis in Healthcare Workers - the Reality of a Portuguese Tertiary Hospital
NCT05847491 ·Status: UNKNOWN
-
Intensive Smoking-cessation Intervention Versus Smoking-cessation Advice in Smear-positive Patients With Pulmonary Tuberculosis
NCT01517022 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of an Enhanced Tuberculosis Infection Control Intervention in Healthcare Facilities in Vietnam and Thailand
NCT02073240 ·Status: COMPLETED
-
Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients
NCT05148949 ·Status: UNKNOWN ·Phase: PHASE4
-
NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis
NCT02371681 ·Status: COMPLETED ·Phase: PHASE2
-
KAP Regarding Tuberculosis Among Physicians in Assiut City
NCT05805878 ·Status: NOT_YET_RECRUITING
-
Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts
NCT02454738 ·Status: COMPLETED ·Phase: NA
-
Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline
NCT06477185 ·Status: RECRUITING ·Phase: PHASE2
-
Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers
NCT02387242 ·Status: SUSPENDED ·Phase: PHASE1
-
SF2000SD Clinical Trial in Zambia
NCT02941159 ·Status: UNKNOWN ·Phase: PHASE1
-
Qualitative Understanding of Community TB Services Pre and Post the CHIP-TB Trial
NCT04494516 ·Status: COMPLETED